SK Biopharmaceuticals Market Cap

SK Biopharmaceuticals has a market cap or net worth of 7.68 trillion as of March 9, 2026. Its market cap has decreased by -21.33% in one year.

Market Cap

7.68T

Enterprise Value

7.49T

Revenue

675.41B

Ranking

n/a

PE Ratio

23.97

Stock Price

98,100.00

Market Cap Chart

Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.68T, a decrease of -22.76%. That is a compound annual growth rate of -4.44%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	7,682.53B	-21.27%
Dec 30, 2025	9,757.83B	12.15%
Dec 30, 2024	8,700.60B	10.66%
Dec 28, 2023	7,862.65B	39.25%
Dec 29, 2022	5,646.39B	-25.82%
Dec 30, 2021	7,612.05B	-42.49%
Dec 30, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
LigaChem Biosciences	7,251.90B
HLB Co., Ltd.	6,749.36B
Peptron	6,132.46B
Voronoi	5,927.74B
OliX Pharmaceuticals	4,179.31B
D&D Pharmatech	3,652.62B
PharmaResearch	3,459.75B
SK bioscience	3,431.52B

Market Cap Rankings